Surgical Options in Malignant Pleural Mesothelioma: Extrapleural Pneumonectomy or Pleurectomy/Decortication

Seminars in Thoracic and Cardiovascular Surgery

Volumn 21, Issue 2, 2009, Pages 149-153

  Flores, Raja M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

extrapleural pneumonectomy; Kaplan Meier survival curves; macroscopic complete resection; pleurectomy decortication

Indexed keywords

CISPLATIN; GEMCITABINE; PEMETREXED;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; DECORTICATION; HUMAN; LUNG RESECTION; MALIGNANT MESOTHELIOMA; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PLEURECTOMY; SURGICAL TECHNIQUE;

CHEMOTHERAPY, ADJUVANT; HUMANS; MESOTHELIOMA; NEOPLASM STAGING; PATIENT SELECTION; PLEURAL NEOPLASMS; PNEUMONECTOMY; RADIOTHERAPY, ADJUVANT; THORACIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 70349743978     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2009.06.008     Document Type: Article

References (25)

1. Flores R.M., Krug L.M., Rosenzweig K.E., et al. Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: A phase II trial. J Thorac Oncol 1 (2006) 289-295
2. Weder W., Kestenholz P., Taverna C., et al. Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22 (2004) 3451-3457
3. Sugarbaker D.J., Flores R.M., Jaklitsch M.T., et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results of 183 patients. J Thorac Cardiovasc Surg 117 (1999) 54-65
4. Martin-Ucar A.E., Nakas A., Edwards J.G., et al. Case control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. EJCTS 31 (2007) 765-770
5. Richards W.G., Zellos L., Bueno R., et al. Phase i to ii study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 24 (2006) 1561-1567
6. Rusch V.W., Rosenzweig K., Venkatraman E., et al. A phase ii trial of surgical resection and adjuvant high dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122 (2001) 788-795
7. Lee T.T., Everett D.L., Shu H.-K.G., et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 124 (2002) 1183-1189
8. Hilaris B.S., Dattatreyudu N., Kwong E., et al. Pleurectomy and intraoperative brachytherapy and postoperative radiation in the treatment of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 10 (1984) 325-331
9. McCormack P.M., Nagasaki F., Hilaris B.S., et al. Surgical treatment of pleural mesothelioma. J Thorac Cardiovasc Surg 84 (1982) 834-842
10. Pass H.I., Temeck B.K., Kranda K., et al. Phase iii randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol 4 (1997) 628-633
11. Lu C., Perez-Soler R., Piperdi B., et al. Phase ii study of a liposome-entrapped cisplatin analog (L-NDDP) administered intrapleurally and pathologic response rates in patients with malignant pleural mesothelioma. J Clin Oncol 23 (2005) 3495-3501
12. Allen K.B., Faber L.P., and Warren W.H. Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin North Am 4 (1994) 113-126
13. Stewart D.J., Martin-Ucar A., Pilling J.E., et al. The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg 78 (2004) 245-252
14. Flores R.M., Pass H.I., Seshan V.E., et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients. J Thorac Cardiovasc Surg 135 (2008) 620-626
15. Sugarbaker D.J. Macroscopic complete resection; the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1 (2006) 175-176
16. In: Greene F.L., Page D.L., Fleming I.D., et al. (Eds). AJCC Cancer Staging Handbook. (ed 6) (2002), Springer-Verlag, New York, NY
17. Flores R.M., Zakowski M., Venkatraman E., et al. Prognostic factors in the treatment of malignant pleural mesothelioma (MPM) at a large Tertiary Referral Center. J Thorac Oncol 2 (2007) 957-965
18. Pass HI, Temeck BK, Kranda K, et al: Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115:310-317v
19. Flores R.M., Routledge T., Seshan V.E., et al. The impact of lymph node station on survival in 348 surgically resected malignant pleural mesothelioma (MPM) patients: Implications for revision of the AJCC staging system. J Thorac Cardiovasc Surg 136 (2008) 605-610
20. Flores R.M., Akhurst T., Gonen M., et al. Positron emission tomography (PET) predicts survival in malignant pleural mesothelioma (MPM). J Thorac Cardiovasc Surg 132 (2006) 763-768
21. Flores R.M., Akhurst T., Gonen M., et al. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 126 (2003) 11-16
22. Pass H.I., Kranda K., Temeck B., et al. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol 4 (1997) 215-222
23. Byrne M.J., Davidson J.A., Musk A.W., et al. Cisplatin and gemcitabine treatment for malignant mesothelioma: A phase II study. J Clin Oncol 17 (1999) 25-30
24. Van Meerbeeck J.P., Gaafar R., Manegold C., et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organization for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23 (2005) 6881-6889
25. Vogelzang N.J., Rusthoven J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 (2003) 2636-2644